Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Chastened By Cold-FX Flop, Afexa Plots U.S. Return Via Botanical Drug Path

Dec 06 2010

• By Dan Schiff

Related Content

FDA Botanical Review Team Clears Green Tea-Based Drug As First Approval

Nov 06 2006

NDA For Cold-fX Could Follow Trial On Treating Cancer-Related Infections

Nov 24 2008

People In Brief

Dec 14 2009

Additional Topics

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window